The trajectory of Viagra presents a intricate picture for shareholders. While the initial launch generated massive gains, the lapse of its patent opened the floodgates to generic competitors, dramatically eroding https://socialclubfm.com/story12444705/the-copyright-and-big-pharma-a-precarious-investment